T Foroud1, J Gray, J Ivashina, P M Conneally. 1. Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis 46202, USA. foroud@medgen.iupui.edu
Abstract
OBJECTIVES: Data from a sample of 2494 patients affected with Huntington's disease (HD), collected as part of the National Research Roster for Huntington Disease Patients and Families, were examined to determine if there was a relation between age at onset and duration of illness. METHODS: Sufficient data for inclusion in analysis was available from 2068 patients, of whom 828 were deceased and 1240 were living. The median duration of disease was 21.4 years with a range of 1.2 to 40.8 years. Patients were categorised into one of four groups based on their age at onset. RESULTS: Significant differences in duration based on the age at onset were found (p<0.025), with juvenile and late onset patients with HD having shorter duration of illness compared with those with an onset between 20-49 years. CONCLUSIONS: Duration of disease is influenced by the age at symptom onset with juvenile and late onset patients having the shortest duration.
OBJECTIVES: Data from a sample of 2494 patients affected with Huntington's disease (HD), collected as part of the National Research Roster for Huntington DiseasePatients and Families, were examined to determine if there was a relation between age at onset and duration of illness. METHODS: Sufficient data for inclusion in analysis was available from 2068 patients, of whom 828 were deceased and 1240 were living. The median duration of disease was 21.4 years with a range of 1.2 to 40.8 years. Patients were categorised into one of four groups based on their age at onset. RESULTS: Significant differences in duration based on the age at onset were found (p<0.025), with juvenile and late onset patients with HD having shorter duration of illness compared with those with an onset between 20-49 years. CONCLUSIONS: Duration of disease is influenced by the age at symptom onset with juvenile and late onset patients having the shortest duration.
Authors: R H Myers; J P Vonsattel; T J Stevens; L A Cupples; E P Richardson; J B Martin; E D Bird Journal: Neurology Date: 1988-03 Impact factor: 9.910
Authors: K Kieburtz; M MacDonald; C Shih; A Feigin; K Steinberg; K Bordwell; C Zimmerman; J Srinidhi; J Sotack; J Gusella Journal: J Med Genet Date: 1994-11 Impact factor: 6.318
Authors: X J Li; S H Li; A H Sharp; F C Nucifora; G Schilling; A Lanahan; P Worley; S H Snyder; C A Ross Journal: Nature Date: 1995-11-23 Impact factor: 49.962
Authors: Y Trottier; D Devys; G Imbert; F Saudou; I An; Y Lutz; C Weber; Y Agid; E C Hirsch; J L Mandel Journal: Nat Genet Date: 1995-05 Impact factor: 38.330
Authors: A Feigin; K Kieburtz; K Bordwell; P Como; K Steinberg; J Sotack; C Zimmerman; C Hickey; C Orme; I Shoulson Journal: Mov Disord Date: 1995-03 Impact factor: 10.338
Authors: Ye Zhang; Rong Ren; Linghui Yang; Junying Zhou; Yun Li; Jie Shi; Lin Lu; Larry D Sanford; Xiangdong Tang Journal: Sleep Date: 2019-10-09 Impact factor: 5.849
Authors: Sheharyar S Baig; Mark Strong; Elisabeth Rosser; Nicola V Taverner; Ruth Glew; Zosia Miedzybrodzka; Angus Clarke; David Craufurd; Oliver W Quarrell Journal: Eur J Hum Genet Date: 2016-05-11 Impact factor: 4.246